Bumper Offer - Urjas oil Just @ Rs. 1
Tacrograf 1 Capsule is a prescription medicine that is available as a Capsule. Liver transplant, Kidney transplant, Heart Transplant are some of its major therapeutic uses. Secondary and off-label uses of Tacrograf 1 Capsule have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Tacrograf 1 Capsule. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
While these are the most often observed Tacrograf 1 Capsule side effects, there are can be others also. These have been listed below. Usually, these side effects of Tacrograf 1 Capsule go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Tacrograf 1 Capsule is Moderate for pregnant women and Moderate for women who are breastfeeding. Further, the section on Tacrograf 1 Capsule related warnings talks about Tacrograf 1 Capsule's effects on the liver, heart and kidney.
Tacrograf 1 Capsule is contraindicated in people with pre-existing medical conditions like Infections, Diabetes Type 2 as it can result in adverse effects. Other conditions have been mentioned below in the Tacrograf 1 Capsule contraindications section.
Additionally, Tacrograf 1 Capsule may also adversely react with other medicines. A complete list of these interactions is given below.
You should also be aware that Tacrograf 1 Capsule is safe while driving, and is addiction.
Tacrograf 1 Capsule is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when Tacrograf 1 Capsule is used -
Moderate
Mild
Is the use of Tacrograf 1 Capsule safe for pregnant women?
Pregnant women may experience moderate side effects from Tacrograf. It is best to stop taking Tacrograf immediately and inform your doctor if you notice any discomfort.
Is the use of Tacrograf 1 Capsule safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Tacrograf. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Tacrograf 1 Capsule on the Kidneys?
There may be some adverse effects on kidney after taking Tacrograf. If you observe any such side effects, stop taking this drug. Consume this medicine again only if your doctor advises you to do so.
What is the effect of Tacrograf 1 Capsule on the Liver?
There may be an adverse effect on the liver after taking Tacrograf. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Tacrograf 1 Capsule on the Heart?
Tacrograf may have severe effects on your heart, so do not take it without first consulting your doctor.
Tacrograf 1 Capsule should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Tacrograf 1 Capsule unless your doctor advises you to do so -
Is this Tacrograf 1 Capsule habit forming or addictive?
Forming a habit of Tacrograf 1 Capsule has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can operate a vehicle or heavy machinery after taking Tacrograf 1 Capsule since it does not cause drowsiness.
Is it safe?
Tacrograf 1 Capsule is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Tacrograf 1 Capsule is not used to treat mental disorders.
Interaction between Food and Tacrograf 1 Capsule
Due to the absence of research, it is difficult to say how Tacrograf 1 Capsule and food will interact.
Interaction between Alcohol and Tacrograf 1 Capsule
Consumption of alcohol and Tacrograf 1 Capsule together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Prograf® (tacrolimus)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 881
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1165-1167
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Prograf® (tacrolimus)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 881
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1165-1167
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Prograf® (tacrolimus)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 881
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1165-1167
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Prograf® (tacrolimus)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 881
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1165-1167
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Prograf® (tacrolimus)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 881
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1165-1167
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Prograf® (tacrolimus)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 881
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1165-1167